| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Jan―03 |
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19 |
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma |
| 2 |
[GO] |
2023―Aug―23 |
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19 |
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma |
| 3 |
[GO] |
2023―Apr―25 |
Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study |
Preeti Chavan, Rajashree Dey, Renita Castelino, Akshay Kamble, Pratik Poladia, Rajani Bagal, et al. (+9) Monica Jadhav, Aditi Shirsat, Ashish Chavan, Sachin Dhumal, Sharath Kumar, Manjunath Nookala Krishnamurty, Vivek Bhat, Atanu Bhattacharjee, Vikram Gota |
| 4 |
[GO] |
2023―Apr―17 |
Ayurvedic medicines in alleviating the symptoms of SARS-CoV-2 omicron variant in North Indian population: a regional genomic study |
Konduru Rama Chandra Reddy, Chetan Sahni, Royana Singh, Hari Chandana, Rohit Sharma |
| 5 |
[GO] |
2022―Sep―27 |
A metabolic blueprint of COVID-19 and long-term vaccine efficacy |
Engin Berber, Deepak Sumbria, Serkan Kokkaya |
| 6 |
[GO] |
2021―Dec―03 |
Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study |
Liliia Fishchuk, Zoia Rossokha, Valeriy Pokhylko, Yuliia Cherniavska, Svitlana Tsvirenko, Serhii Kovtun, et al. (+3) Nataliia Medvedieva, Viktoriia Vershyhora, Nataliia Gorovenko |
| 7 |
[GO] |
2021―Apr―05 |
Drugs intervention study in COVID-19 management |
Muhammad Taher, Noratika Tik, Deny Susanti |
| 8 |
[GO] |
2021―Apr―05 |
A review on the clinical trials of repurposing therapeutic drugs, mechanisms and preventive measures against SARS-CoV-2 |
Eleazer U. Ikonne, Victor O. Ikpeazu, Ositadinma C. Ugbogu, Okezie Emmanuel, Ikechukwu P. Nwakuche, Emeka J. Iweala, Eziuche A. Ugbogu |
| 9 |
[GO] |
2021―Mar―26 |
CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine |
Mohammad Salem Hareedy, Sonya Mohamed Rashad, Helal F. Hetta, Sara Mahmoud Hassanien, Hebatallah Abdellatif, Manal Hassanien |
| 10 |
[GO] |
2021―Jan―14 |
Clinically important drug-drug interactions in patients admitted to hospital with COVID-19: drug pairs, risk factors, and management |
Amir Ali Mahboobipour, Shadi Baniasadi |
| 11 |
[GO] |
2020―Sep―24 |
Understanding COVID-19 in the light of epidemic disease described in Unani medicine |
Md Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Umme Ayman, Shabnam Ansari, Mariyam Ahad |
|
